Sign inJoin waitlistJoin the waitlist

Jennifer Reichek

Director, STAR Program (Survivors Taking Action · McGaw Medical Center of Northwestern University

Credentials: · · · · ·

History

McGaw Medical Center of Northwestern University
Present

Pediatric Hematology Oncology
Children's Hospital of Philadelphia
2005–2008
Pediatrics
Children's Hospital of Philadelphia
2002–2005
Drexel University College of Medicine
1998–2002

Research

Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group
Clinical Cancer Research · 2011 · First of 9 authors · 52 citations
Clinical research participation among adolescent and young adults at an NCI-designated Comprehensive Cancer Center and affiliated pediatric hospital
Supportive Care in Cancer · 2017 · 41 citations
Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem…
Journal of Pediatric Hematology/Oncology · 2018 · 29 citations

David Walterhouse
7 papers
YG
Yasmin Gosiengfiao
5 papers
Amy Armstrong
4 papers · 4 as a resident
Stacy Sanford
3 papers
Amy Walz
2 papers · 1 as a fellow
Angela Waanders
2 papers
Aniket Saha
2 papers
Jennifer Carrera
2 papers
Michael Roth
2 papers
Michael Terao
2 papers
Nupur Mittal
2 papers
Rachel Werk
2 papers · 2 as a fellow

Clinical trials

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Site PI · Recruiting · Phase 2
Children's Oncology Group
2024–2027
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2022–2030